Fig 1.
Example choice question in module 1.
Table 1.
Attributes and levels in module 1.
Fig 2.
Example choice question in module 2.
Table 2.
Attributes and levels in module 2.
Table 3.
Summary of general characteristics in the sample.
Table 4.
Responses to survey-comprehension questions.
Table 5.
Number of conditions reported in survey screening question.
Table 6.
Consistency of respondent reports.
Fig 3.
Latent-class model mean preference results and 95% CIs: Class 1 (Class% = 72.1).
CIs = Confidence intervals; IV = Intravenous; CAR-T = Chimeric Antigen Receptor; BiTE® = Bispecific T-Cell Engager; ADC = Anti-Drug Conjugate PFS = Progression-free survival; GI = Gastrointestinal, CNS = Central Nervous System; CRS = Cytokine Release Syndrome. Class % is the average probability of classification into the class across respondents.
Fig 4.
Latent-class model mean preference results and 95% CIs: Class 2 (Class% = 28.9).
CIs = Confidence intervals; IV = Intravenous; CAR-T = Chimeric Antigen Receptor; BiTE® = Bispecific T-Cell Engager; ADC = Anti-Drug Conjugate PFS = Progression-free survival; GI = Gastrointestinal, CNS = Central Nervous System; CRS = Cytokine Release Syndrome. Class% is the average probability of classification into the class across respondents.
Table 7.
Membership estimates for being a member of Class 2 relative to Class 1.
Fig 5.
Weighted RPL mean preference results with 95% CIs (N = 323).
CIs = Confidence intervals; IV = Intravenous; CAR-T = Chimeric Antigen Receptor; BiTE® = Bispecific T-Cell Engager; ADC = Anti-Drug Conjugate PFS = Progression-free survival; GI = Gastrointestinal, CNS = Central Nervous System; CRS = Cytokine Release Syndrome.